Transcriptomic analysis of autistic brain reveals convergent molecular pathology
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 19 of the 32 sources its claims cite were checked for support.
Abstract
Autism spectrum disorder (ASD) is a common, highly heritable neurodevelopmental condition characterized by marked genetic heterogeneity. Thus, a fundamental question is whether autism represents an aetiologically heterogeneous disorder in which the myriad genetic or environmental risk factors perturb common underlying molecular pathways in the brain. Here, we demonstrate consistent differences in transcriptome organization between autistic and normal brain by gene co-expression network analysis. Remarkably, regional patterns of gene expression that typically distinguish frontal and temporal cortex are significantly attenuated in the ASD brain, suggesting abnormalities in cortical patterning. We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1 (also known as FOX1), and a module enriched for immune genes and glial markers. Using high-throughput RNA sequencing we demonstrate dysregulated splicing of A2BP1-dependent alternative exons in the ASD brain. Moreover, using a published autism genome-wide association study (GWAS) data set, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism. In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic aetiology for this process. Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.
Overview
CoChat Summary
TL;DR
This study used post-mortem brain transcriptomics and co-expression network analysis to show that autism spectrum disorder (ASD) cortex has convergent molecular abnormalities, including attenuated frontal-temporal regional expression differences and distinct neuronal and immune-glial co-expression modules. It further links a down-regulated neuronal module to autism genetic association signals and demonstrates A2BP1-dependent differential splicing in ASD brain.
Key findings
- In autism cortex, 444 genes were differentially expressed (DE) versus controls, while only 2 genes were DE in cerebellum; the 209 down-regulated genes were enriched for synaptic function and the 235 up-regulated genes for immune/inflammatory response. In an independent BA44/45 replication cohort, 97 genes were DE and 81 overlapped with the initial cohort (p=1.2E-93), with the same direction of change for all but 2 of the 81.
- Regional cortical patterning was attenuated in ASD: 174 genes were DE between control BA9 and BA41 at FDR<1%, but none were DE in the same regional comparison among ASD cases; relaxing to FDR 5% identified over 500 DE genes in controls and only 8 in ASD brains.
- Weighted gene co-expression network analysis identified an under-expressed neuronal module (M12) enriched for known autism susceptibility genes (p=6.1E-4), including CADPS2, AHI1, CNTNAP2, and SLC25A12, and an up-regulated immune-glial module (M16). M12 showed significant enrichment for autism GWAS association signals (p=5E-4), whereas M16 and the DE gene list did not.
- RNA-Seq on 3 ASD samples with low A2BP1 and 3 controls identified 212 significant alternative splicing events; 36 overlapped with predicted A2BP1/2 targets (p=2.2E-16), and RT-PCR confirmed 85% of tested differential splicing changes involving predicted A2BP1 targets.
Methods
- Post-mortem brain tissue was obtained from the Autism Tissue Project, Harvard Brain Bank, and MRC London Brain Bank. Illumina microarrays profiled superior temporal gyrus (BA41/42), prefrontal cortex (BA9), and cerebellar vermis; after filtering, 58 cortex samples (29 ASD, 29 controls) and 21 cerebellum samples (11 ASD, 10 controls) were analyzed, with an independent BA44/45 replication cohort of 9 ASD cases and 5 controls.
- Analyses included differential expression, supervised hierarchical clustering, weighted gene co-expression network analysis (WGCNA), gene ontology enrichment, and GWAS set enrichment using a published autism GWAS dataset plus negative-control GWAS datasets.
- High-throughput RNA-Seq was performed on 3 ASD samples with significant A2BP1 down-regulation (average fold change by qRT-PCR: 5.9) and 3 control samples with average A2BP1 levels, followed by RT-PCR validation.
Limitations
- The paper does not include a dedicated limitations section.
- The text makes evident that the RNA-Seq comparison used a very small sample (3 ASD, 3 controls) and the replication cohort was also small (9 ASD, 5 controls).
- The study relies on post-mortem brain tissue; potential confounders such as age, sex, RNA integrity number, post-mortem interval, seizure co-morbidity, and medication were assessed, but the authors state that immune changes have no evidence of a common genetic component and are most likely secondary or environmental.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 8 Not checked · 93 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The hubs of M12, i.e. the genes with the highest rank of M12 membership 8 , were A2BP1, APBA2, SCAMP5, CNTNAP1, KLC2, CHRM1 (Supplementary Data).”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The citation is attached to the definition of module membership used to identify hubs, not to the six-gene list, which the citing sentence attributes to its Supplementary Data. The Results section (“Module membership is highly consistent”; page unavailable) defines module membership, and the Methods section (“Defining a measure of module membership (kME)”; page unavailable) explains how genes are ranked by it. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The control brain network showed high similarity with the previously described human brain co-expression networks (Supplementary Table 7), consistent with the existence of robust modules of co-expressed genes related to specific cell types and biological functions 8 .”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The citation supports the sentence’s final clause: the Results sections ‘Conserved modules are enriched for markers of cell classes’ and ‘Relationships between modules are highly preserved’ describe reproducible co-expression modules associated with cell types and biological functions. The similarity of the citing authors’ control network to earlier networks is their own comparison, reported in their Supplementary Table 7, rather than a finding attributed to this source. Page numbers were not available in our copy. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“M12 showed significant overrepresentation of known autism susceptibility genes 2 (Supplementary Table 10; p = 6.1E-4), including CADPS2 , AHI1 , CNTNAP2 , and SLC25A12”
What the sources say
- Partly supportedcites [2] 2. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010; 466:368-372. [PubMed: 20531469] sourceExperimental — accuracy not yet measured
The main text (Figure 2 and the accompanying results; page not provided) discusses a set of ASD-implicated genes, supporting the general description attached to citation 2. Our copy does not identify CADPS2, AHI1, CNTNAP2, or SLC25A12 as members of that set, so it cannot verify the specific examples. The M12 enrichment and p value are presented as the citing paper’s own analysis, not as findings of this source. (LLM, conf=0.77)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The first three of these genes have previously been implicated in autism 14-16”
What the sources say
- Not checked — no full text of the sourcecites [14] 14. Babatz TD, Kumar RA, Sudi J, Dobyns WB, Christian SL. Copy number and sequence variants implicate APBA2 as an autism candidate gene. Autism Res. 2009; 2:359-364. [PubMed: 20029827] source
- Supportedcites [15] 15. Castermans D, Volders K, Crepel A, Backx L, De Vos R, Freson K, Meulemans S, Vermeesch JR, Schrander-Stumpel CT, De Rijk P, et al. SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles. Hum Mol Genet. 2010; 19:13681378. [PubMed: 20071347] source
The Abstract identifies SCAMP5 as a candidate gene for autism and reports its disruption in a patient with autism. In the citing sentence’s group of three references, this paper supports the SCAMP5 portion of the claim. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [16] 16. Martin CL, Duvall JA, Ilkin Y, Simon JS, Arreaza MG, Wilkes K, Alvarez-Retuerto A, Whichello A, Powell CM, Rao K, et al. Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet. 2007; 144B:869-876. [PubMed: 17503474] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“showed significant similarity to two modules identified in previous studies of normal human brain 8 : an astrocyte module and a microglial module.”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The Results section identifies a module of coexpressed genes with characteristics of microglia in human brain. The citation identifies the earlier microglial module; the statement that the citing study’s M16 was significantly similar to it is the citing authors’ comparison, not a finding attributed to Oldham et al. No page number is available in our copy. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
95 more claims · 6 with their cited sources checked
Create a free account to see all 117 claims and every source verdict.
- It may state two separate claims as one. 14
- Probably not a substantial claim. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although there was no significant DGE in the cerebellum (FDR < 0.05, P distributions in Fig. 1b), similar to observations in a smaller cohort8, there was a replication signal in the cerebellum and overall concordance between ASD-related fold changes in the cortex and cerebellum (Extended Data Fig. 2f–h).”
From Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism (2016) · cites this paper as [8]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results are consistent with previous studies in post-mortem brain that identified dysregulation of gene expression in microglia but enriched expression of ASD risk genes only in neuronal cells (Ruzzo et al., 2019; Gandal et al., 2018a, 2018b; Voineagu et al., 2011).”
From Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism (2020) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gene expression changes in postmortem brain overlap with developmentally regulated genes involved in cortical patterning as well as in cell cycle, proliferation and neural differentiation6, 7.”
From Altered proliferation and networks in neural cells derived from idiopathic autistic individuals (2017) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upregulation of immune genes and downregulation of synaptic genes was observed in postmortem brain from idiopathic ASD (Voineagu et al., 2011), and this finding has been replicated in a larger ASD sample (Gupta et al., 2014).”
From Getting to the cores of autism (2019) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis was supported both by the significant overlap between candidate autism-susceptibility genes and Rbfox target genes and by the significant overlap of predicted Rbfox target exons and exons altered in autistic brains with down-regulation of Rbfox1 (Voineagu et al., 2011).”
From HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism (2014) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measured
81 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Self-citationA General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684 · cited 5×
“We next applied weighted-gene co-expression network analysis (WGCNA) 8; 9 to integrate the expression differences observed between autistic and control cerebral cortex into a higher order, systems level context.”
InfluentialSelf-citationPan, Q., Shai, O., Lee, L. J., Frey, B. J., & Blencowe, B. J. (2008) · Nature Genetics · doi:10.1038/ng.259 · Cited by 3,951
Self-citationCahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Self-citationFunctional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 1×
“These results indicate that (1) M12 consists of a set of genes that are supported by independent lines of evidence to be causally involved in ASD pathophysiology, and (2) the upregulation of immune response genes in the autistic brain observed by us and others(25) has no evidence of a common genetic component.”
Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R
Langfelder, P., Zhang, B., & Horvath, S. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm563 · Cited by 1,892
Self-citationAdvances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · cited 3×
“%) showed significant overlap with the previously described human brain modules (Supplementary Table 6), indicating that many features reflecting the general organization of the autism brain transcriptome are consistent with that of the normal human brain.”
InfluentialSelf-citationDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602
Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · cited 1×
“In addition, comparison of these DE results with another, smaller study of the STG in ASD 7 , revealed significant consistency at the level of DE genes, including down-regulation of DLX1 and AHI1 (Supplementary Table 5).”
Research works printed but not linked: 1
- 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] · DOI · Paper page
Cited by
Items 101–200 of 1,888
A comprehensive evaluation of module detection methods for gene expression data
Saelens, W., Cannoodt, R., & Saeys, Y. (2018) · Nature Communications · doi:10.1038/s41467-018-03424-4 · Cited by 311
“Note that classical scores comparing clusterings, such as the Rand index, the F1, or the normalized mutual information, could not be used as these scores are unable to handle overlap and/or overlap 59 (Supplementary Note 1).”
BackgroundMethodInfluentialNeuroimmunology and neuroepigenetics in the establishment of sex differences in the brain
McCarthy, M. M., Nugent, B. M., & Lenz, K. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.61 · Cited by 314
Errant gardeners: glial-cell-dependent synaptic pruning and neurodevelopmental disorders
Neniskyte, U., & Gross, C. T. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.110 · Cited by 313
Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment
Goines, P. E., & Ashwood, P. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.07.006 · Cited by 314
Altered neural connectivity in excitatory and inhibitory cortical circuits in autism
Zikopoulos, B., & Barbas, H. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00609 · Cited by 313
“…growth, synapse formation, and synaptic transmission of excitatory and inhibitory neurons (see Samaco et al., 2005; Hogart et al., 2007; Weiss et al., 2009; Gilman et al., 2011; Hallmayer et al., 2011; Hussman et al., 2011; Voineagu et al., 2011; Shulha et al., 2012; reviewed in Geschwind, 2011).”
BackgroundYan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“Transcriptomic analysis of autistic brains has found 444 genes showing signi fi cant expression changes in PFC, but only 2 in the cerebellum [123].”
BackgroundThe conundrums of understanding genetic risks for autism spectrum disorders
State, M. W., & Levitt, P. (2011) · Nature Neuroscience · doi:10.1038/nn.2924 · Cited by 306
Histone Acetylome-wide Association Study of Autism Spectrum Disorder
Sun, W., Poschmann, J., Cruz-Herrera del Rosario, R., Parikshak, N. N., Hajan, H. S., Kumar, V., Ramasamy, R., Belgard, T. G., Elanggovan, B., Wong, C. C. Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.031 · Cited by 306
“An earlier transcriptomic study revealed a similar pattern of changes shared by many, but not all, ASD cases (Voineagu et al., 2011).”
InfluentialSelf-citationAmeis, S. H., & Catani, M. (2015) · Cortex · doi:10.1016/j.cortex.2014.10.014 · Cited by 301
Network Organization of the Huntingtin Proteomic Interactome in Mammalian Brain
Shirasaki, D. I., Greiner, E. R., Al-Ramahi, I., Gray, M., Boontheung, P., Geschwind, D. H., Botas, J., Coppola, G., Horvath, S., Loo, J. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.05.024 · Cited by 297
Self-citationSey, N. Y. A., Hu, B., Mah, W., Fauni, H., McAfee, J. C., Rajarajan, P., Brennand, K. J., Akbarian, S., & Won, H. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0603-0 · Cited by 297
Gene expression in human brain implicates sexually dimorphic pathways in autism spectrum disorders
Werling, D. M., Parikshak, N. N., & Geschwind, D. H. (2016) · Nature Communications · doi:10.1038/ncomms10717 · Cited by 296
Self-citationThe GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders
Braat, S., & Kooy, R. F. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.042 · Cited by 294
Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders
Siniscalco, D., Schultz, S., Brigida, A. L., & Antonucci, N. (2018) · Pharmaceuticals · doi:10.3390/ph11020056 · Cited by 293
“Dysregulated microglial responses co-expressed with altered neuronal activity-dependent genes in ASD brains were also detected by transcriptome analysis [69,70].”
BackgroundGaiteri, C., Ding, Y., French, B., Tseng, G. C., & Sibille, E. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12106 · Cited by 289
“Practically, hubs provide a specific focus for investigations into disease-correlated modules of genes (next section), (Miller et al. 2008; Ray et al. 2008; Torkamani et al. 2010; Voineagu et al. 2011).”
BackgroundInfluentialMicroglia and the brain: Complementary partners in development and disease
Hammond, T. R., Robinton, D., & Stevens, B. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100616-060509 · Cited by 288
Microglia in the Cerebral Cortex in Autism
Tetreault, N. A., Hakeem, A. Y., Jiang, S., Williams, B. A., Allman, E., Wold, B. J., & Allman, J. M. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1513-0 · Cited by 288
“In a recent microarray analysis of gene expression in brains of individuals with autism compared to controls, Voineagu et al. (2011) found a module of enriched immune and microglial genes, although these genes have not been found in genome wide association studies that have sought to identify genes…”
BackgroundSchafer, S. T., Paquola, A. C. M., Stern, S., Gosselin, D., Ku, M., Pena, M., Kuret, T. J. M., Liyanage, M., Mansour, A. A., Jaeger, B. N., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0295-x · Cited by 288
Getting to the cores of autism
Iakoucheva, L. M., Muotri, A. R., & Sebat, J. (2019) · Cell · doi:10.1016/j.cell.2019.07.037 · Cited by 260
“Upregulation of immune genes and downregulation of synaptic genes was observed in postmortem brain from idiopathic ASD (Voineagu et al., 2011), and this finding has been replicated in a larger ASD sample (Gupta et al.”
ResultGene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms
Tordjman, S., Somogyi, E., Coulon, N., Kermarrec, S., Cohen, D., Bronsard, G., Bonnot, O., Weismann-Arcache, C., Botbol, M., Lauth, B., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00053 · Cited by 283
“Such a genetic basis of synaptic and neuronal signaling dysfunction in ASD has been confirmed by recent findings (50) demonstrating differences in transcriptome organization between autistic and normal brain through gene co-expression network analysis.”
ResultXu, X., Wells, A. B., O'Brien, D. R., Nehorai, A., & Dougherty, J. D. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4488-13.2014 · Cited by 282
“Transcriptome profiling A recent tour-de-force gene expression study screened postmortem cortical tissue from 29 individuals with autism and matched controls (Voineagu et al., 2011).”
BackgroundMethodResultInfluentialMandy, W., & Lai, M. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12501 · Cited by 283
“Neuro-immune processes are not only key to the neurobiological characteristics of individuals with ASC themselves (Voineagu et al., 2011), but such processes may also play a contributing’ role in atypical neurodevelopment as early as the gestational period and may explain the pathogenesis of the autism phenotype in a…”
BackgroundPhase Separation as a Missing Mechanism for Interpretation of Disease Mutations
Tsang, B., Pritišanac, I., Scherer, S. W., Moses, A. M., & Forman-Kay, J. D. (2020) · Cell · doi:10.1016/j.cell.2020.11.050 · Cited by 281
“Splicing Transcriptome-wide dysregulation of mRNA splicing levels has been observed in post-mortem brains of people with ASD (Gandal et al., 2018; Irimia et al., 2014; Voineagu et al., 2011).”
BackgroundAutism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators
Duffney, L. J., Zhong, P., Wei, J., Matas, E., Cheng, J., Qin, L., Ma, K., Dietz, D. M., Kajiwara, Y., Buxbaum, J. D., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.064 · Cited by 281
“Juvenile male Shank3 +/ D C mice and age-matched wild-type mice were subject to the three-chamber social interaction assay (Wang et al., 2011; Won et al., 2012).”
InfluentialγCaMKII Shuttles Ca2+/CaM to the Nucleus to Trigger CREB Phosphorylation and Gene Expression
Ma, H., Groth, R. D., Cohen, S. M., Emery, J. F., Li, B., Hoedt, E., Zhang, G., Neubert, T. A., & Tsien, R. W. (2014) · Cell · doi:10.1016/j.cell.2014.09.019 · Cited by 277
Arcuri, C., Mecca, C., Bianchi, R., Giambanco, I., & Donato, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00191 · Cited by 279
Machine Learning in Genomic Medicine: A Review of Computational Problems and Data Sets
Leung, M. K. K., Delong, A., Alipanahi, B., & Frey, B. J. (2016) · Proceedings of the IEEE · doi:10.1109/jproc.2015.2494198 · Cited by 275
“For example, transcriptomic analyses have found consistent deviations in AS patterns in the cortical regions of autism spectrum disorder (ASD) cases [62], [63], pointing to splicing misregulation as an ASD mechanism.”
BackgroundDisruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions
Nussbacher, J. K., Tabet, R., Yeo, G. W., & Lagier-Tourenne, C. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.014 · Cited by 272
Broad transcriptomic dysregulation occurs across the cerebral cortex in ASD
Gandal, M. J., Haney, J. R., Wamsley, B., Yap, C. X., Parhami, S., Emani, P. S., Chang, N., Chen, G. T., Hoftman, G. D., de Alba, D., et al. (2022) · Nature · doi:10.1038/s41586-022-05377-7 · Cited by 271
“(4) A permuted distribution of the difference in differentially expressed genes between regions for ASD vs control subjects was generated to test the ‘true’ difference.”
BackgroundSelf-citationMicroglia in CNS development: Shaping the brain for the future
Mosser, C.-A., Baptista, S., Arnoux, I., & Audinat, E. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.01.002 · Cited by 268
“Moreover, RNA-sequencing indicates an association between ASD and the expression of genes related to microglia activation (Voineagu et al., 2011).”
DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways
Nardone, S., Sharan Sams, D., Reuveni, E., Getselter, D., Oron, O., Karpuj, M., & Elliott, E. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.70 · Cited by 266
Germline Chd8 haploinsufficiency alters brain development in mouse
Gompers, A. L., Su-Feher, L., Ellegood, J., Copping, N. A., Riyadh, M. A., Stradleigh, T. W., Pride, M. C., Schaffler, M. D., Wade, A. A., Catta-Preta, R., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4592 · Cited by 266
“Finally, we observed enrichment ( P = 0.012) between DE upregulated genes and genes associated with immune response that were upregulated in cortex from postmortem ASD brains 23,24 .”
InfluentialAn in vivo neuroimmune organoid model to study human microglia phenotypes
Schafer, S. T., Mansour, A. A., Schlachetzki, J. C. M., Pena, M., Ghassemzadeh, S., Mitchell, L., Mar, A., Quang, D., Stumpf, S., Ortiz, I. S., et al. (2023) · Cell · doi:10.1016/j.cell.2023.04.022 · Cited by 267
The fetal origins of mental illness
al-Haddad, B. J. S., Oler, E., Armistead, B., Elsayed, N. A., Weinberger, D. R., Bernier, R., Burd, I., Kapur, R., Jacobsson, B., Wang, C., et al. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.06.013 · Cited by 261
Filice, F., Vörckel, K. J., Sungur, A. Ö., Wöhr, M., & Schwaller, B. (2016) · Molecular Brain · doi:10.1186/s13041-016-0192-8 · Cited by 240
“node in gene networks [4, 81, 82] to represent a convergence of mechanisms relating to ASD, in line with previous propositions [83–85].”
ResultCurrent Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
Eissa, N., Al-Houqani, M., Sadeq, A., Ojha, S. K., Sasse, A., & Sadek, B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00304 · Cited by 260
“Moreover, genetic studies revealed that alteration in the developmental pathways of neuronal and axonal structures that are strongly involved in synaptogenesis emerge from single gene mutations (Geschwind, 2011; Voineagu et al., 2011; Chang et al., 2015).”
BackgroundInnate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD)
Hughes, H. K., R.J.Moreno, & Ashwood, P. (2023) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.12.001 · Cited by 263
“The second module associated with ASD was enriched in overexpressed immune genes, and later work by this same group supported these findings (Voineagu, 2011; Parikshak, 2016).”
Wöhr, M., Orduz, D., Gregory, P., Moreno, H., Khan, U., Vörckel, K. J., Wolfer, D. P., Welzl, H., Gall, D., Schiffmann, S. N., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.19 · Cited by 258
“Genome-wide association studies 5,6 and transcriptomic co-expression network analyses 7 have identi fi ed ASD risk gene networks.”
Cytoplasmic Rbfox1 Regulates the Expression of Synaptic and Autism-Related Genes
Lee, J.-A., Damianov, A., Lin, C.-H., Fontes, M., Parikshak, N. N., Anderson, E. S., Geschwind, D. H., Black, D. L., & Martin, K. C. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.025 · Cited by 232
“Three of these coexpression modules, devM13, devM16, and devM17, were enriched for the GO term of synaptic transmission, as well as ASD susceptibility genes (Parikshak et al., 2013).”
BackgroundResultInfluentialSelf-citationSignalling pathways in autism spectrum disorder: mechanisms and therapeutic implications
Jiang, C.-C., Lin, L.-S., Long, S., Ke, X.-Y., Fukunaga, K., Lu, Y.-M., & Han, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01081-0 · Cited by 258
“Interestingly, the predicted targets of the differentially expressed miRNAs were enriched with genes related to neurobiology, the cell cycle, and cell signalling and largely overlapped with genes previously identified via differential mRNA expression analysis of ASD patients.(30,275) Considering that miRNAs can be del…”
BackgroundResultThe Emerging Picture of Autism Spectrum Disorder: Genetics and Pathology
Chen, J. A., Peñagarikano, O., Belgard, T. G., Swarup, V., & Geschwind, D. H. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040405 · Cited by 254
Self-citationNanoplastics Promote Microcystin Synthesis and Release from Cyanobacterial Microcystis aeruginosa
Feng, L.-J., Sun, X.-D., Zhu, F.-P., Feng, Y., Duan, J.-L., Xiao, F., Li, X.-Y., Shi, Y., Wang, Q., Sun, J.-W., et al. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.9b06085 · Cited by 246
Guidance for RNA-seq co-expression network construction and analysis: safety in numbers
Ballouz, S., Verleyen, W., & Gillis, J. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv118 · Cited by 215
“…the first co-expression analyses, there are studies which are highly targeted toward conditions of interest with networks derived from relatively small numbers of samples (dozens to the low hundreds) and often focusing on broad network changes in some condition of interest (Voineagu et al. , 2011).”
BackgroundThe discovery of integrated gene networks for autism and related disorders
Hormozdiari, F., Penn, O., Borenstein, E., & Eichler, E. E. (2015) · Genome Research · doi:10.1101/gr.178855.114 · Cited by 249
Sex and gender in neurodevelopmental conditions
Bölte, S., Neufeld, J., Marschik, P. B., Williams, Z. J., Gallagher, L., & Lai, M.-C. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00774-6 · Cited by 249
The Role of Epigenetic Change in Autism Spectrum Disorders
Loke, Y. J., Hannan, A. J., & Craig, J. M. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00107 · Cited by 246
Intellectual disability and autism spectrum disorders: Causal genes and molecular mechanisms
Srivastava, A. K., & Schwartz, C. E. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.015 · Cited by 249
“Several studies suggest that the changes in neuronal gene expression controlled by selective expression of transcription factors affect the formation of dendritic spines and synapses (Ben-David and Shifman, 2012; Ebert and Greenberg, 2013; Voineagu et al., 2011; West and Greenberg, 2011).”
BackgroundThe many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245
“These findings have been noted in the brain [96-99], gastrointestinal tract [100,101], and peripheral blood [102,103].”
BackgroundImmune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders
Hughes, H. K., Mills Ko, E., Rose, D., & Ashwood, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00405 · Cited by 245
Kratsman, N., Getselter, D., & Elliott, E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.003 · Cited by 239
“In a whole throughput gene transcription study, Voineagu et al. documented an increase in immune response gene expression, and a decrease in synaptic gene expression, in the frontal cortex of individuals with autism (Voineagu et al., 2011).”
BackgroundHuman brain organogenesis: Toward a cellular understanding of development and disease
Kelley, K. W., & Pașca, S. P. (2022) · Cell · doi:10.1016/j.cell.2021.10.003 · Cited by 239
“Genomicmeasurements from postmortem tissue have provided broad surveys of altered molecular pathways, such as gene expression changes in ASD (Voineagu et al., 2011) and synaptic gene expression differences in schizophrenia (Fromer et al.”
BackgroundInfluentialGenomics, convergent neuroscience and progress in understanding autism spectrum disorder
Willsey, H. R., Willsey, A. J., Wang, B., & State, M. W. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-022-00576-7 · Cited by 229
Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons
Griesi-Oliveira, K., Acab, A., Gupta, A. R., Sunaga, D. Y., Chailangkarn, T., Nicol, X., Nunez, Y., Walker, M. F., Murdoch, J. D., Sanders, S. J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.141 · Cited by 236
Paolicelli, R. C., & Ferretti, M. T. (2017) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2017.00009 · Cited by 236
“Human epidemiological data have shown clear associations between exposure to early-life adverse events and risk of neuropsychiatric conditions later in life (MacMillan et al., 2001), including depression (Agid et al., 1999; St Clair et al., 2015), autism spectrum disorders (ASDs) (Kinney et al., 2008) and psychosis (V…”
BackgroundInfluentialViral manipulation of functionally distinct interneurons in mice, non-human primates and humans
Vormstein-Schneider, D., Lin, J. D., Pelkey, K. A., Chittajallu, R., Guo, B., Arias-Garcia, M. A., Allaway, K., Sakopoulos, S., Schneider, G., Stevenson, O., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0692-9 · Cited by 235
Emerging roles of TET proteins and 5-hydroxymethylcytosines in active DNA demethylation and beyond
Guo, J. U., Su, Y., Zhong, C., Ming, G.-L., & Song, H. (2011) · Cell Cycle · doi:10.4161/cc.10.16.17093 · Cited by 235
Cohen, S. M., Tsien, R. W., Goff, D. C., & Halassa, M. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.026 · Cited by 232
“In fact, many proteins involved in these pathways, including the CaV1 channel, calcineurin, CaMKIIβ and CaMKIIγ, and BDNF and its receptor TrkB have all been linked to schizophrenia and related neuropsychiatric disorders such as autism (Gerber et al., 2003; Glausier and Lewis, 2011; Lewis et al., 2011, 2012; Voineagu…”
BackgroundGenetics and epigenetics of autism spectrum disorder—current evidence in the field
Wiśniowiecka-Kowalnik, B., & Nowakowska, B. A. (2019) · Journal of Applied Genetics · doi:10.1007/s13353-018-00480-w · Cited by 231
Meredith, R. M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.001 · Cited by 232
Translational animal models of autism and neurodevelopmental disorders
Crawley, J. N. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.3/jcrawley · Cited by 230
An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
A Quantitative Framework to Evaluate Modeling of Cortical Development by Neural Stem Cells
Stein, J. L., de la Torre-Ubieta, L., Tian, Y., Parikshak, N. N., Hernández, I. A., Marchetto, M. C., Baker, D. K., Lu, D., Hinman, C. R., Lowe, J. K., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.035 · Cited by 201
Self-citationKim, Y. S., & Leventhal, B. L. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.001 · Cited by 227
“org/journ individuals with autism (102).”
The role of sex-differential biology in risk for autism spectrum disorder
Werling, D. M. (2016) · Biology of Sex Differences · doi:10.1186/s13293-016-0112-8 · Cited by 208
“Instead, the results showed significant overlap between genes with higher expression in males [113] and genes up-regulated in post mortem autistic brain relative to similarly male-skewed control groups [114, 115].”
ResultWidespread RNA editing dysregulation in brains from autistic individuals
Tran, S. S., Jun, H.-I., Bahn, J. H., Azghadi, A., Ramaswami, G., Van Nostrand, E. L., Nguyen, T. B., Hsiao, Y.-H. E., Lee, C., Pratt, G. A., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0287-x · Cited by 218
Self-citationRBFOX1 regulates both splicing and transcriptional networks in human neuronal development
Fogel, B. L., Wexler, E., Wahnich, A., Friedrich, T., Vijayendran, C., Gao, F., Parikshak, N., Konopka, G., & Geschwind, D. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds240 · Cited by 216
“This lack of strong overlap indicates that the relationship between RBFOX1 function and neurodevelopmental disease is unlikely to occur primarily due to the direct RBFOX1controlled missplicing of known disease genes, as was suggested by previous analysis of the ASD brain (15).”
BackgroundResultInfluentialSelf-citationMicroglia Gone Rogue: Impacts on Psychiatric Disorders across the Lifespan
Tay, T. L., Béchade, C., D’Andrea, I., St-Pierre, M.-K., Henry, M. S., Roumier, A., & Tremblay, M.-E. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00421 · Cited by 216
“…microglia in ASD is supported by postmortem transcriptional analyses showing an upregulation of gene expression modules enriched with microglial markers (Voineagu et al., 2011), and genes associated with an anti-inflammatory state and the anti-viral type-I interferon pathway (Gupta et al., 2014).”
BackgroundDefective control of pre–messenger RNA splicing in human disease
Chabot, B., & Shkreta, L. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201510032 · Cited by 213
Abnormal microglial–neuronal spatial organization in the dorsolateral prefrontal cortex in autism
Morgan, J. T., Chana, G., Abramson, I., Semendeferi, K., Courchesne, E., & Everall, I. P. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.036 · Cited by 214
The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function
Gehman, L. T., Meera, P., Stoilov, P., Shiue, L., O'Brien, J. E., Meisler, M. H., Ares, M., Otis, T. S., & Black, D. L. (2012) · Genes & Development · doi:10.1101/gad.182477.111 · Cited by 213
“Studies of both human neurological disease mutations andmousemodels have linked Rbfox proteins to epilepsy, ataxia, and autism spectrum disorder (Bhalla et al. 2004; Barnby et al. 2005; Martin et al. 2007; Sebat et al. 2007; Voineagu et al. 2011).”
BackgroundBrain adaptation and alternative developmental trajectories
Johnson, M. H., Jones, E. J. H., & Gliga, T. (2015) · Development and Psychopathology · doi:10.1017/s0954579415000073 · Cited by 213
“In ASD, although early deficits in synaptic functioning are likely wide-spread, spatiotemporal profiles of gene expression indicate that some areas of the brain are likely more affected than others (Voineagu et al., 2011).”
InfluentialA Short Review on the Current Understanding of Autism Spectrum Disorders
Park, H. R., Lee, J. M., Moon, H. E., Lee, D. S., Kim, B.-N., Kim, J., Kim, D. G., & Paek, S. H. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.1.1 · Cited by 210
“Genetic studies suggested that single gene mutations alter developmental pathways of neuronal and axonal structures involved in synaptogenesis [20-22].”
BackgroundChronic cocaine-regulated epigenomic changes in mouse nucleus accumbens
Feng, J., Wilkinson, M., Liu, X., Purushothaman, I., Ferguson, D., Vialou, V., Maze, I., Shao, N., Kennedy, P., Koo, J., et al. (2014) · Genome Biology · doi:10.1186/gb-2014-15-4-r65 · Cited by 198
“Similar implication of A2BP1 targets in neural transmission, neuronal development, and maturation genes has been demonstrated in autism spectrum disorder and human neural stem cell studies [61,69].”
BackgroundChow, M. L., Pramparo, T., Winn, M. E., Barnes, C. C., Li, H.-R., Weiss, L., Fan, J.-B., Murray, S., April, C., Belinson, H., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002592 · Cited by 202
“In studies combining both young and adult autistic brain tissue, transcript and protein expression patterns suggest that cortical patterning, synaptic [20], apoptotic [21], immune [20,22], and inflammatory [23] aberrances in addition to dysregulation of neurotransmitter systems [24] may be involved in autism.”
BackgroundInfluentialImmunological and autoimmune considerations of Autism Spectrum Disorders
Gesundheit, B., Rosenzweig, J. P., Naor, D., Lerer, B., Zachor, D. A., Procházka, V., Melamed, M., Kristt, D. A., Steinberg, A., Shulman, C., et al. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.05.005 · Cited by 207
Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses
Won, H., Mah, W., & Kim, E. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00019 · Cited by 206
Gandal, M. J., Sisti, J., Klook, K., Ortinski, P. I., Leitman, V, Liang, Y., Thieu, T., Anderson, R., Pierce, R. C., Jonak, G., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.69 · Cited by 204
Aberrant Expression of Long Noncoding RNAs in Autistic Brain
Ziats, M. N., & Rennert, O. M. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9880-8 · Cited by 201
“This finding is in agreement with a recent large transcriptome study in autistic brains by Voineagu et al., where they demonstrated dysregulated splicing of A2BP1-dependent exons in ASD brains using RNA-seq (Voineagu et al. 2011).”
BackgroundResultInfluentialLombardo, M. V., Moon, H. M., Su, J., Palmer, T. D., Courchesne, E., & Pramparo, T. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.15 · Cited by 201
“The first was a microarray dataset from Voineagu et al. 52 (GEO Accession ID: GSE28521) comprising frontal (BA9) and superior temporal cortex (BA41/42) tissue.”
InfluentialTakata, A., Matsumoto, N., & Kato, T. (2017) · Nature Communications · doi:10.1038/ncomms14519 · Cited by 197
“More recently, it was reported that a subset of de novo germline mutations, whose important roles in the genetic aetiology of neuropsychiatric disorders such as autism spectrum disorders (ASDs) and schizophrenia has been established 6–10 , probably contribute to the risk of ASD and schizophrenia by affecting AS 11 .”
Prenatal Origins of ASD: The When, What, and How of ASD Development
Courchesne, E., Gazestani, V. H., & Lewis, N. E. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.03.005 · Cited by 193
Epigenetic Signatures of Autism: Trimethylated H3K4 Landscapes in Prefrontal Neurons
Shulha, H. P. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.151 · Cited by 196
Shared Molecular Neuropathology Across Major Psychiatric Disorders Parallels Polygenic Overlap
Gandal, M. J., Haney, J. R., Parikshak, N. N., Leppa, V., Ramaswami, G., Hartl, C., Schork, A. J., Appadurai, V., Buil, A., Werge, T. M., et al. (2019) · Focus · doi:10.1176/appi.focus.17103 · Cited by 195
Self-citationGenome-wide, integrative analysis implicates microRNA dysregulation in autism spectrum disorder
Wu, Y. E., Parikshak, N. N., Belgard, T. G., & Geschwind, D. H. (2016) · Nature Neuroscience · doi:10.1038/nn.4373 · Cited by 195
Self-citationDuffy, F. H., & Als, H. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-64 · Cited by 194
“[12] provided strong evidence to suggest widespread transcriptional and splicing dysregulation as the key mechanism underlying brain dysfunction in ASD.”
BackgroundMitochondrial abnormalities in temporal lobe of autistic brain
Tang, G., Gutierrez Rios, P., Kuo, S.-H., Akman, H. O., Rosoklija, G., Tanji, K., Dwork, A., Schon, E. A., DiMauro, S., Goldman, J., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.006 · Cited by 194
Activity-Dependent Human Brain Coding/Noncoding Gene Regulatory Networks
Lipovich, L., Dachet, F., Cai, J., Bagla, S., Balan, K., Jia, H., & Loeb, J. A. (2012) · Genetics · doi:10.1534/genetics.112.145128 · Cited by 193
“mRNAs and lncRNAs with respect to brain activity is complementary to other human brain transcriptome studies such as those focusing on developmental, regional, and disease-related gene expression patterns (JOHNSON et al. 2009; VOINEAGU et al. 2011),”
BackgroundWhat does CNTNAP2 reveal about autism spectrum disorder?
Peñagarikano, O., & Geschwind, D. H. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.01.003 · Cited by 190
Self-citationRomero-Garcia, R., Warrier, V., Bullmore, E. T., Baron-Cohen, S., & Bethlehem, R. A. I. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0023-7 · Cited by 188
“Evidence from rare genetic variants [54, 55] and transcriptionally dysregulated genes in autism have highlighted a role for synaptic transmission in the aetiology of autism [28, 29].”
BackgroundAutism genetics: searching for specificity and convergence
Berg, J. M., & Geschwind, D. H. (2012) · Genome Biology · doi:10.1186/gb-2012-13-7-247 · Cited by 192
“One recent study used a sophisticated systems biology approach, weighted gene coexpression network analysis (WGCNA), to build transcriptome networks from human ASD and control postmortem brain samples [142].”
BackgroundMethodSelf-citationPsychiatric Disorders: Diagnosis to Therapy
Krystal, J. H., & State, M. W. (2014) · Cell · doi:10.1016/j.cell.2014.02.042 · Cited by 190
AutismKB: an evidence-based knowledgebase of autism genetics
Xu, L.-M., Li, J.-R., Huang, Y., Zhao, M., Tang, X., & Wei, L. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1145 · Cited by 179
“The result is consistent with recent findings that synapse development, axon targeting and neuron motility are related to autism etiology (60,61).”
ResultBehavior genetics and postgenomics
Charney, E. (2012) · Behavioral and Brain Sciences · doi:10.1017/s0140525x11002226 · Cited by 189
Gene networks specific for innate immunity define post-traumatic stress disorder
Breen, M. S., Maihofer, A. X., Glatt, S. J., Tylee, D. S., Chandler, S. D., Tsuang, M. T., Risbrough, V. B., Baker, D. G., O'Connor, D. T., Nievergelt, C. M., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.9 · Cited by 180
Astrocytes and Microglia and Their Potential Link with Autism Spectrum Disorders
Petrelli, F., Pucci, L., & Bezzi, P. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00021 · Cited by 189
“…influences interact with genetic susceptibility: for example, recent studies have shown that glial cells in the brains of autistic subjects were constantly activated and their inflammation response genes were turned on (Voineagu et al., 2011; Edmonson et al., 2014; Gupta et al., 2014).”
BackgroundResultBiomarkers in autism spectrum disorder: the old and the new
Ruggeri, B., Sarkans, U., Schumann, G., & Persico, A. M. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3290-7 · Cited by 188
“…proteins functionally linked into biochemical pathways most relevant to autism (van der Zwaag et al. 2009; Anney et al. 2011; Gilman et al. 2011; Voineagu et al. 2011; Ben-David and Shifman 2012; Kou et al. 2012; Lee et al. 2012; Skafidas et al. 2012; Noh et al. 2013; Poelmans et al. 2013).”
BackgroundKenny, E. M., Cormican, P., Furlong, S., Heron, E., Kenny, G., Fahey, C., Kelleher, E., Ennis, S., Tropea, D., Anney, R., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.127 · Cited by 185
Genetic contributions to autism spectrum disorder
Havdahl, A., Niarchou, M., Starnawska, A., Uddin, M., van der Merwe, C., & Warrier, V. (2021) · Psychological Medicine · doi:10.1017/s0033291721000192 · Cited by 179
“Most commonly reported three pathways (Ayhan & Konopka, 2019; Gordon et al., 2019; Voineagu et al., 2011) associated with autism.”
BackgroundUnifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops
Mullins, C., Fishell, G., & Tsien, R. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.017 · Cited by 167
Chakravarty, S., Reddy, B. R., Sudhakar, S. R., Saxena, S., Das, T., Meghah, V., Brahmendra Swamy, C. V., Kumar, A., & Idris, M. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063302 · Cited by 185
“The proteins aldolase C, beta synuclein and parvalbumin isoform 2 (PVALB2) are implicated in neurological conditions such as Alzheimer’s, Parkinson’s [56], Ischemia [57] and autism [58], as well as in mood disorders [34–37].”
Background
Metadata
- Authors
- Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H.
- Affiliations
- University of California, Los Angeles (US)
- University of Toronto (CA)
- King's College London (GB)
- Corresponding author
- Geschwind, Daniel H.
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7351
- Pages
- 380-384
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3607626
- OpenAlex
- W1995647101
- Cited by
- 1,874
- References
- 38
- Citations by year
- 2026: 91 · 2025: 93 · 2024: 95 · 2023: 111 · 2022: 112 · 2021: 141 · 2020: 131 · 2019: 142 · 2018: 132 · 2017: 127 · 2016: 143 · 2015: 136 · 2014: 137 · 2013: 124 · 2012: 120
- FWCI
- 67.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Autism Speaks
- Genome Canada
- Ontario Genomics Institute
- National Institutes of Health (5r01mh094714-04)
- Canadian Institutes of Health Research
- Medical Research Council
- National Institute of Mental Health (R01-MH094714, R01MH081754, R37MH060233)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, transcriptome, gene co-expression network, splicing dysregulation, A2BP1, alternative exons, autism susceptibility genes, neuronal dysfunction, genetic heterogeneity
- MeSH terms
- RNA Splicing Factors, Autistic Disorder, Brain, Exons, Frontal Lobe, Gene Expression Regulation, Humans, Temporal Lobe, Transcription, Genetic, Case-Control Studies, RNA-Binding Proteins, Alternative Splicing, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.